No Data
No Data
Senti Biosciences Granted US Patent #12005081 For "Chimeric Receptors And Methods Of Use For Acute Myeloid Leukemia Cancer Antigen Targets" Today
Senti Biosciences Granted US Patent #12005081 For "Chimeric Receptors And Methods Of Use For Acute Myeloid Leukemia Cancer Antigen Targets" Today
12 Health Care Stocks Moving In Friday's After-Market Session
GainersAnitra (AMEX:AZTR) stock rose 17.0% to $0.17 during Friday's after-market session. The company's market cap stands at $5.0 million. Scinai Immunotherapeutics (NASDAQ:SCNI) stock increased by 12
Kronos Bio Hires Ex-Senti Bio CFO to Head Finances, Operations
By Dean Seal Kronos Bio has hired the former chief financial officer of Senti Bio to helm its finances and also serve as chief operating officer. The biotechnology company said Tuesday that Deborah
Senti Biosciences Announces Executive Leadership Restructuring
Express News | Senti Biosciences Inc: Kanya Rajangam Appointed as President of Company Effective May 14
Express News | Senti Bio Doses First Patient In Phase 1 Trial Of SENTI-202 In Relapsed Or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
No Data